Concepedia

K.S. Gajiwala

KG

Statistics

Publications

38

Citations

11.3K

H-Index

28

Active since

1995

Affiliations

Pfizer (United States)(Current)

Howard Hughes Medical Institute

Utah State University

Rockefeller University

Texas A&M University

K.S. Gajiwala is an author at Pfizer (United States) specializing in life sciences, molecular biology, and drug discovery.

ORCID

Publications per year

1995–2025

38

Publications

38

Weight-Reducing Effects of the Plasma Protein Encoded by the <i>obese</i> Gene

Jeffrey L. Halaas, K.S. Gajiwala, Margherita Maffei et al. · Science · 1995 · 4.5K citations

, , +17

An oral SARS-CoV-2 M <sup>pro</sup> inhibitor clinical candidate for the treatment of COVID-19

Dafydd R. Owen, Charlotte Allerton, Annaliesa S. Anderson et al. · Science · 2021 · 1.9K citations · Full text

, , +13

Contribution of hydrogen bonds to protein stability

C. Nick Pace, Hailong Fu, Katrina Lee Fryar et al. · Protein Science · 2014 · 586 citations · Full text

, , +13

Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19

Robert L. Hoffman, Robert S. Kania, Mary A. Brothers et al. · Journal of Medicinal Chemistry · 2020 · 533 citations · Full text

, , +15

Contribution of Hydrophobic Interactions to Protein Stability

C. Nick Pace, Hailong Fu, Katrina Lee Fryar et al. · Journal of Molecular Biology · 2011 · 460 citations

, , +12

1–5 of 38